Jalra-M 50mg/500mg Tablet

Product Introduction

Jalra-M 50mg/500mg Tablet SR is a prescription medication used primarily in the management of type 2 diabetes mellitus. It combines two active ingredients: Vildagliptin and Metformin. Vildagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor, which helps increase insulin production and decrease glucagon levels in the blood. Metformin is a biguanide, which works by decreasing glucose production in the liver and improving insulin sensitivity in the body’s cells.

This combination medication is designed to help control blood sugar levels in adults with type 2 diabetes when diet and exercise alone are insufficient. The “SR” in the tablet name stands for “Sustained Release,” indicating that the medication is released slowly over time to provide a more consistent effect and potentially reduce the frequency of dosing.

Uses of Jalra-M 50mg/500mg Tablet

Jalra-M 50mg/500mg Tablet SR is used for the following purposes:

1. Type 2 Diabetes Management: It is prescribed for the management of type 2 diabetes mellitus, especially when blood glucose levels are not adequately controlled with diet and exercise alone. It is used as part of a comprehensive diabetes management plan, which may include diet, exercise, and other medications.
2. Blood Sugar Control: The primary aim of this medication is to help lower and maintain blood glucose levels within the target range. It works by improving the body’s response to insulin and reducing the amount of sugar produced by the liver.
3. Combination Therapy: Jalra-M can be used in combination with other antidiabetic agents such as sulfonylureas or insulin if blood sugar levels are still not well controlled with a single medication.

Benefits of Jalra-M 50mg/500mg Tablet

1. Effective Blood Glucose Control: Jalra-M helps achieve better control over blood sugar levels in patients with type 2 diabetes. By combining Vildagliptin and Metformin, it leverages the benefits of both medications, improving overall glycemic control.
2. Reduced Risk of Hypoglycemia: Compared to some other antidiabetic medications, Jalra-M has a lower risk of causing hypoglycemia (low blood sugar levels), particularly when used alone or with Metformin.
3. Convenient Dosing: The sustained-release formulation means that the medication is released slowly, which can improve adherence to the treatment regimen and potentially reduce the number of doses needed per day.
4. Improved Insulin Sensitivity: Metformin improves the body’s sensitivity to insulin, which helps in reducing insulin resistance and managing blood glucose levels more effectively.
5. Weight Management: Unlike some other antidiabetic drugs, Metformin, one of the components of Jalra-M, is generally associated with weight neutrality or modest weight loss rather than weight gain.

Side Effects of Jalra-M 50mg/500mg Tablet

While Jalra-M 50mg/500mg Tablet SR is effective, it may cause side effects in some individuals. Common side effects include:

1. Gastrointestinal Issues: These may include nausea, vomiting, diarrhea, abdominal pain, and bloating. These effects are often temporary and may improve with continued use or adjustment of the dosage.
2. Hypoglycemia: Although the risk is lower compared to other antidiabetic agents, Jalra-M can still cause low blood sugar levels, particularly if used in combination with other glucose-lowering medications.
3. Lactic Acidosis: A rare but serious side effect of Metformin is lactic acidosis, a condition where lactic acid builds up in the blood. Symptoms include unusual muscle pain, breathing difficulties, and weakness. This condition requires immediate medical attention.
4. Skin Reactions: Some patients might experience rashes or other skin reactions.
5. Allergic Reactions: Although rare, severe allergic reactions such as swelling of the face, lips, or throat can occur. Seek medical help if these symptoms are observed.
6. Vitamin B12 Deficiency: Long-term use of Metformin can lead to decreased absorption of Vitamin B12, potentially leading to deficiency. Regular monitoring may be required.

FAQ

1. How should Jalra-M be taken? Jalra-M 50mg/500mg Tablet SR should be taken orally, usually once or twice daily with meals to reduce the risk of gastrointestinal side effects. Follow your doctor’s instructions on dosing and do not chew or crush the tablet.

2. What should I do if I miss a dose? If you miss a dose of Jalra-M, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double up on doses to make up for a missed dose.

3. Can Jalra-M be used during pregnancy? Jalra-M is not generally recommended during pregnancy. If you are pregnant or planning to become pregnant, consult your healthcare provider to discuss alternative options for managing diabetes.

4. Are there any dietary restrictions while using Jalra-M? While using Jalra-M, maintaining a balanced diet is essential. Your healthcare provider will provide specific dietary guidelines tailored to your needs. It is important to monitor your blood glucose levels regularly.

5. Can Jalra-M interact with other medications? Yes, Jalra-M can interact with other medications, including over-the-counter drugs, supplements, and other prescription medications. Inform your healthcare provider about all the medications you are taking to avoid potential interactions.

6. How should I store Jalra-M? Store Jalra-M at room temperature, away from moisture and heat. Keep it out of reach of children.

Disclaimer

Singhla Medicos primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Singhla Medicos. Our mission is to support, not replace, the doctor-patient relationship.